Sign In
Buy FENC
$9.14
-0.84 (-8.42%)
At Close: Jun 03, 2026
Fennec Announces Proposed Public Offering of Common Shares
08:01pm, Wednesday, 29'th Apr 2020
Fennec Pharmaceuticals Inc. (FENC) (FRX.TO), a specialty pharmaceutical company focused on the development of PEDMARK™ (a unique formulation of sodium thiosulfate) for the prevention of platinum-in
Fennec Pharmaceuticals (FENC) Receives a Buy from H.C. Wainwright
11:22am, Wednesday, 15'th Apr 2020
H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Fennec Pharmaceuticals (FENC) today and set a price target of $17.00. The company's
Fennec Pharmaceuticals (FENC) Receives a Buy from H.C. Wainwright
11:22am, Wednesday, 15'th Apr 2020
H.C. Wainwright analyst
Ram Selvaraju
reiterated a
Buy
rating on Fennec Pharmaceuticals (
FENC
–
Research Report
) today and set a price target of
$17.00
. The company’s shares closed last Tuesday
Alnylam's Blackstone Funding, And Other News: The Good, Bad And Ugly Of Biopharma
10:10pm, Tuesday, 14'th Apr 2020
Alnylam received $2bn funding from Blackstone. NextCure postpones trial launch due to coronavirus. Fennec Pharmaceuticals' NDA is accepted by the FDA.
We're Not Very Worried About Fennec Pharmaceuticals's (NASDAQ:FENC) Cash Burn Rate
01:14pm, Tuesday, 14'th Apr 2020
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Fennec Pharmaceuticals Announces FDA Filing Acceptance and Priority Review of New Drug Application for PEDMARK™
11:08am, Monday, 13'th Apr 2020
Fennec Pharmaceuticals Inc. (Nasdaq: FENC; TSX: FRX), a specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing and granted Priority
Critical Comparison: Fennec Pharmaceuticals (NASDAQ:FENC) vs. Sutro Biopharma (NASDAQ:STRO)
07:50am, Monday, 16'th Mar 2020
Fennec Pharmaceuticals (NASDAQ:FENC) and Sutro Biopharma (NASDAQ:STRO) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strengt
Fennec Announces Issuance of U.S. Patent for Use of PEDMARK™
12:00pm, Thursday, 05'th Mar 2020
RESEARCH TRIANGLE PARK, N.C., March 05, 2020 -- Fennec Pharmaceuticals Inc. (Nasdaq: FENC; TSX: FRX), a specialty pharmaceutical company focused on the development of.
Fennec Pharmaceuticals Inc. (Nasdaq: FENC; TSX: FRX), a specialty pharmaceutical company, today announced that the company’s Marketing Authorization Application (MAA) for its investigational drug, s
Advance Auto Parts, Cree among Triangle companies hit as stocks tumble with rising concern over coronavirus
07:59pm, Monday, 24'th Feb 2020
Stock markets took a hit Monday from growing concerns over the spread of the coronavirus.
Fennec Provides Business Update and Announces Fiscal Year 2019 Financial Results
11:00am, Friday, 14'th Feb 2020
NDA (New Drug Application) and Marketing Authorization Application (MAA) completed in February 2020Commercial readiness activities in U.S. underway for potential launch of.
S, TMUS among premarket gainers
02:18pm, Tuesday, 11'th Feb 2020
Sprint (NYSE:S) +74% after judge approves T-Mobile merger.Rexahn Pharmaceuticals (NASDAQ:REXN) +25%.ZK International Group (NASDAQ:ZKIN) +21% on supplying stainless steel pipe and fitting products f
Fennec Pharmaceuticals Inc. (Nasdaq:FENC; TSX: FRX), a specialty pharmaceutical company, today announced it has completed its rolling submission of a New Drug Application (NDA) to the U.S. Food and D
3 Healthcare Stocks That Can Double This Year
05:30pm, Wednesday, 29'th Jan 2020
Which names are capable of hitting the ball out of the park? The pros will say healthcare stocks. Rookies and seasoned Street veterans alike argue the space contains exciting investment opportunities,
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on Jan. 13.) Arvinas Inc (NASDAQ: ARVN ) Baxter Int
